DekaBank Deutsche Girozentrale
KZR

DekaBank Deutsche Girozentrale’s Kezar Life Sciences KZR Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,000
Closed -$61K – 1285
2023
Q1 		$61K Hold
2,000
– – ﹤0.01% 1265
2022
Q4 		$143K Hold
2,000
– – ﹤0.01% 1267
2022
Q3 		$169K Hold
2,000
– – ﹤0.01% 1253
2022
Q2 		$156K Buy
+2,000
New +$176K ﹤0.01% 1233

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DekaBank Deutsche Girozentrale's KZR Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of Kezar Life Sciences (KZR) in Q2 2023, closing a stake of 2,000 shares — an estimated $61K sold.

DekaBank Deutsche Girozentrale first reported a position in KZR in Q2 2022 and held it in 4 quarters. The position peaked at $169K in Q3 2022. 104 funds tracked by Wall St. Rank hold KZR as of Q2 2023.

  • DekaBank Deutsche Girozentrale reported no remaining Kezar Life Sciences position as of Q2 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 2,000 Kezar Life Sciences shares in Q2 2023, an estimated $61K.
  • DekaBank Deutsche Girozentrale first reported a position in Kezar Life Sciences in Q2 2022 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's Kezar Life Sciences position peaked at $169K in Q3 2022.
  • 104 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.